Table 3.
Individual participant clinical characteristics (n=23)
| Code | Sex | Age | Diagnosis* | Pain duration (months) | Mental health conditions (yes/no) | Mental health duration (months) | ÖMSQ (possible score 1–100) | HADS (total: possible score 0–42) | PSEQ [possible score 0–60] | CSQ (catastrophising subscale; [possible score 0–36] | AQoL-8D; (MSD; possible score 0–100) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IP01 | F | 21 | JIA; fibromyalgia* | 90 | N | 43 | 8 | 43 | 13 | 69 | |
| IP02 | F | 23 | Fibromyalgia* | 84 | Y | 12 | 53 | 17 | 40 | 18 | 49 |
| IP03 | F | 24 | Neck/shoulders/back | 72 | Y | 48 | 45 | 15 | 46 | 3 | 61 |
| IP04 | F | 22 | Neck/back pain | 58 | Y | 37 | 57 | 25 | 43 | 9 | 29 |
| IP05 | F | 24 | Low back pain | 54 | N | 27 | 14 | 39 | 18 | 72 | |
| IP06 | F | 19 | Bilateral knee pain | 60 | N | 27 | 14 | 60 | 1 | 74 | |
| IP07 | F | 20 | Back pain/sciatica* | 38 | Y | 120 | 73 | 18 | 21 | 29 | 52 |
| IP08 | F | 24 | Shoulder/back* | 14 | Y | 34 | 40 | 22 | 52 | 6 | 54 |
| IP09 | M | 22 | AS*† | 84 | Y | 36 | 41 | 25 | 18 | 16 | 40 |
| IP010 | F | 20 | JIA* | 240 | Y | 12 | 60 | 14 | 46 | 6 | 60 |
| IP11 | F | 20 | CTD*‡ | 35 | Y | 60 | 49 | 26 | 38 | 5 | 33 |
| IP12 | F | 19 | Hips/knees/back | 60 | Y | 144 | 50 | 14 | 39 | 15 | 64 |
| IP13 | M | 21 | Back pain* | 32 | Y | 32 | 36 | 10 | 57 | 18 | 71 |
| IP14 | F | 24 | Fibromyalgia* | 37 | N | 42 | 10 | 46 | 18 | 74 | |
| IP15 | F | 24 | Ankylosing spondylitis/OP* | 54 | N | 33 | 9 | 37 | 6 | 70 | |
| IP16 | M | 22 | Low back pain/sciatica* | 56 | N | 33 | 5 | 60 | 8 | 87 | |
| IP17 | F | 23 | Inflammatory arthritis§/OA* | 126 | N | 31 | 4 | 56 | 4 | 79 | |
| IP18 | F | 19 | Fibromyalgia* | 87 | N | 52 | 10 | 45 | 18 | 59 | |
| FG01 | F | 18 | Knee pain* | 36 | N | 38 | 6 | 54 | 5 | 77 | |
| FG02 | F | 18 | Scoliosis (back)* | 90 | Y | 96 | 56 | 17 | 38 | 16 | 51 |
| FG03¶ | F | 17 | 38 | Y** | 20 | 2 | 57 | 6 | 71 | ||
| FG04¶ | F | 18 | Low back/hip pain*†† | 8 | Y | 6 | 47 | 17 | 10 | 26 | 48 |
| FG05¶ | F | 18 | 5 | Y | 39 | 45 | 27 | 54 | 11 | 56 |
Except where indicated otherwise, values are presented as n (percentages).
*Clinical diagnosis made by health professional.
†Also pituitary adenoma and acromegaly.
‡Unspecified Connective Tissue Disorder with Sjogren's features.
§Seronegative.
¶No specific clinical diagnosis was available from transcripts due to confidentiality requirements of the FG.
**Previously history of clinically diagnosed anxiety but now resolved.
††Comorbid endometriosis.
AQoL-8D, The Assessment of Quality of Life Eight Dimension Scale (psychological super dimension only); AS, ankylosing spondylitis; CSQ, Coping Strategies Questionnaire-Pain Factor 2: catastrophising subscale; CTD, connective tissue disorder; FG, focus group participant; HADS, Hospital Anxiety and Depression Scale; HADS-A, anxiety subscale; HADS-D, depression subscale; IP, individual participant; JIA, juvenile inflammatory arthritis; OA, osteoarthritis; ÖMSPQ-SF 10, Orebro Musculoskeletal Pain Screening Questionnaire-Short Form 10; OP, osteoporosis; PSEQ, Pain Self-Efficacy Questionnaire.